Due to anticipated high temperatures this weekend, we are unable to ship pharmaceutical orders. Any pharmaceutical orders placed today will ship early next week.
Due to anticipated high temperatures this weekend, we are unable to ship pharmaceutical orders. Any pharmaceutical orders placed today will ship early next week.
-
Extensive product ranges
-
Unrivalled customer care, knowledge and support
-
Log in for best experience
Menquadfi meningococcal (group A,C,W,Y) conjugate vaccine 0.5ml solution for injection POM X 1
Add to wish list
Create new list
ℹ Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises.
Non-approved buyers:
Complete our Online POM Form, and we will notify you once your account is Pharma approved.
What is Menquafi used for?:
MenQuadfi is designed to help protect individuals aged 12 months and older against IMD caused by serogroups A, C, W and Y. It is the only MenACWY conjugate vaccine in Europe available in a fully liquid formulation.9,10 This can potentially save time and reduce reconstitution errors.
MenQuadfi uses a tetanus toxoid carrier protein, which is able to impact the T-cell dependent immune system.
In clinical trials, the safety of MenQuadfi was shown to be similar to comparator vaccines.
A MenACWY certificate will be provided on ordering MenQuadfi.
Neisseria meningitidis bacteria (also called meningococci) can be passed from person to person and can cause serious and sometimes life-threatening infections, such as:
• Meningitis – an inflammation of the tissues that surround the brain and spinal cord;
• Septicemia – an infection of the blood
Patient info leaflet link: